Mahamaya Lifesciences IPO was subscribed overall 1.63 times on the last day, while the retail quota was subscribed 1.02 times, QIB subscribed 1.19 times, and NII quota subscribed 3.63 times, respectively.
Details About Mahamaya Lifesciences IPO
Mahamaya Lifesciences has received approval from SEBI for an IPO of ₹70.44 crores. The IPO comprises a fresh issue of ₹64.28 crores and offer for sale up to 5,40,800 equity shares with face value of ₹10 each.
Moreover, the company has set up a price band between ₹108 to ₹114 per share. In this IPO total of 2,400 shares were available in 2 lot sizes for the minimum Retail category, and for the maximum Retail category.
S-HNI (Min) has a total of 3,600 shares in 3 lot sizes. S-HNI (Maximum) has a total of 8,400 shares in 7 lot sizes. Lastly, for B-HNI (Minimum) has a total of 9,600 in 8 lot sizes.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of maximum investment of ₹2,73,600.
- S-HNI (Minimum): Minimum investment of ₹4,10,400.
- S-HNI (Maximum): Maximum investment of ₹9,57,600.
- B-HNI (Minimum): Minimum investment of ₹10,94,400.
Subscription duration of the Mahamaya Lifesciences IPO
The opening date of the Mahamaya Lifesciences IPO subscription was November 11, 2025, and the closing date was November 13, 2025. The Mahamaya Lifesciences IPO allotment was finalized on November 14, 2025, and the IPO listing is on November 18, 2025.
Funds Deployment of This Company
- Purchase of Equipment for the existing Formulation plant.
- Funding capital expenditure towards setting up a new Technical manufacturing plant.
- Construction of Warehouse Building and Purchase of Machinery.
- Funding the working capital requirement of the Company.
- Lastly, the remaining funds will be used for the company’s general corporate purposes.
About Mahamaya Lifesciences IPO
Mahamaya Lifesciences Limited, founded in 2002, is one of the leading companies that focuses on the manufacturing of pesticide formulations and supplies bulk formulations. By working with the Central Insecticides Board and Registration Committee (CIBRC), the company started its business with the import and registration of major pesticide molecules that were not produced in India. After successful registration, they decided to market these molecules as technical products to both Indian agrochemical companies as well as multinational corporations (MNCs).
Since its incorporation in 2002, the company has grown significantly by setting up its own manufacturing plant in December 2021 at Dahej, Gujarat.
